[HTML][HTML] Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR/Cas9

Y Wang, L Hao, H Wang, K Santostefano, A Thapa… - Molecular Therapy, 2018 - cell.com
Abstract Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion
within the 3'-untranslated region (3'-UTR) of the Dystrophia Myotonica protein kinase gene …

[HTML][HTML] Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9

Y Wang, L Hao, H Wang, K Santostefano… - Molecular …, 2018 - ncbi.nlm.nih.gov
Abstract Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion
within the 3′ UTR of the Dystrophia Myotonica protein kinase gene. In this study, we …

[HTML][HTML] Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9

Y Wang, L Hao, H Wang, K Santostefano, A Thapa… - Molecular Therapy, 2018 - Elsevier
Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion within the
3′ UTR of the Dystrophia Myotonica protein kinase gene. In this study, we explored …

[PDF][PDF] Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9

Y Wang, L Hao, H Wang, K Santostefano… - Molecular …, 2018 - scienceopen.com
Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion within the
3 0 UTR of the Dystrophia Myotonica protein kinase gene. In this study, we explored …

Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.

Y Wang, L Hao, H Wang, K Santostefano… - … Therapy: the Journal …, 2018 - europepmc.org
Abstract Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion
within the 3′ UTR of the Dystrophia Myotonica protein kinase gene. In this study, we …

[PDF][PDF] Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9

Y Wang, L Hao, H Wang, K Santostefano… - Molecular …, 2018 - myotonicdystrophy.com
Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion within the
3 0 UTR of the Dystrophia Myotonica protein kinase gene. In this study, we explored …

[引用][C] Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9

Y Wang, L Hao, H Wang, K Santostefano, A Thapa… - Molecular …, 2018 - cir.nii.ac.jp
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索フォ恁啶匾動 …

Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9

Y Wang, L Hao, H Wang… - … therapy: the journal …, 2018 - pubmed.ncbi.nlm.nih.gov
Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion within the
3'UTR of the Dystrophia Myotonica protein kinase gene. In this study, we explored …

Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.

Y Wang, L Hao, H Wang, K Santostefano… - … Therapy: the Journal …, 2018 - europepmc.org
Abstract Myotonic dystrophy type 1 (DM1) is caused by a CTG nucleotide repeat expansion
within the 3′ UTR of the Dystrophia Myotonica protein kinase gene. In this study, we …